Nutritional Intravenous (IV) Therapy is a procedure that allows very high amounts of specific nutrients to treat and enhance multiple functions of the body. The advantage of administering high-dose nutrients in an intraveneous manner allows more vitamins and minerals to be delivered directly to the necessary tissues and cells at a very high dose. Typically only certain amounts of vitamins and minerals can be absorbed through the gastrointestinal system. Sometimes people don't feel the effects of these nutrients when taken in an oral manner because not enough was absorbed to create a therapeutic effect. Aging, genetics, biochemical variations and digestive disorders may further impair absorption. By recieving high dose nutrients intraveneously, these factors of absorption are reduced and individuals typically benefit from the therapy.
At the Health Integration Center, we typically perform bloodwork before we recommend IV therapy. Blood work should be performed, especially when it comes to IV Vitamin C therapy. Certain individuals have a condition called G6PD (glucose-6 phosphate dehydrogenase) deficiency which is a key enzyme necessary for proper function of red blood cells. After blood work is performed and a health assessment is determined, different IV therapies can be recommended based on your diagnosis and symptoms.
At the Health Integration Center the doctors may customize certain nutrients based on your symptoms. In general we offer some of the more known therapies which will be discussed below.
Administering a vitamin and mineral formula (known as the “Myers cocktail”) intravenously may be useful in treating a variety of medical problems, according to a report in Alternative Medicine Review (2002;7:389–403). Although few studies have been published on this therapy, many physicians have observed its benefit in treating migraine headaches, fatigue, allergies, heart disease, acute asthma attacks, fibromyalgia, infections, and other conditions.
IV (intravenous) vitamin C therapy has already been clinically proven to markedly improve quality of life for cancer patients, but a new landmark study has shown for the first time it can reduce inflammation and tumor markers in prostate cancer and breast cancer patients. The science behind IV vitamin C as a cancer therapy is now advancing faster than ever before, with six clinical trials currently underway worldwide, including colorectal, prostate, pancreatic and other cancers. In lab studies, high-dose vitamin C has proven to be potently cytotoxic to a wide variety of cancer cell lines as well as to boost the cytotoxicity of several common chemotherapy drugs. This has been confirmed in animal studies, where IV vitamin C decreases the growth rates of liver, ovarian, pancreatic, and glioblastoma tumors with dosages easily achievable in humans. But beyond directly poisoning cancer cells, there is another role for vitamin C to play in treating cancer: the reduction of inflammation. Recent research has shown that greater inflammation in cancer patients is associated with poor prognosis. This may be because key features of the inflammatory environment (infiltrating leucocytes, pro-inflammatory cytokine build-up, tissue remodeling and angiogenesis) may actually facilitate cancer development. With this in mind, one of the leading alternative medicine clinics in the USA designed a trial to test the ability of IV vitamin C to reduce key inflammation markers as well as tumor markers in patients with prostate, breast and other cancers. This trial included 45 patients aged 47-85, with an average age of 68. The treatments included vitamin C infusions of 25 to 50 grams, up to three times per week. The median follow-up on patients was 7.2 years (maximum of 18 years). It should be noted that most patients had already been treated by standard therapies. The total number of vitamin C infusions given to any one patient ranged from 1 up to 102. IV vitamin C therapy was successful in reducing C Reactive Protein (CRP) levels in 76 percent of all patients in the trial. This is significant, as CRP is a well-established marker for inflammation. By the end of the trial, the average patient saw a drop in CRP levels of 80 percent (for patients who started the trials with above-normal CRP levels). In addition, for a more detailed picture, serum levels of pro-inflammatory cytokines were measured for 11 patients. Of these 11 patients, all saw large reductions in these cytokines after their treatments. Some important trends emerged from the trial. First, patients who had more IV vitamin C treatments tended to have a better response. Second, patients who began the therapy at an earlier stage of their disease had better response compared to those with more aggressive, metastatic cancer. Finally, and perhaps most importantly, patients who saw reductions in inflammation markers usually also saw reductions in tumor markers - especially for breast and prostate cancer. Most impressive with this trial was that PSA levels decreased in 77 percent of prostate cancer patients while 73 percent of breast cancer patients saw decreases in CA27.29/CA15.3 (cancer antigen) and/or CEA (carcinoembryonic antigen) after their treatments.
Chelation is a chemical process in which a metal or mineral—such as lead, mercury, or calcium—is bonded to another substance. This is a natural process that goes on continually in our bodies. However, our bodies evolved in a less polluted world and they are not prepared to handle the heavy load of environmental toxins to which they are now confronted with on a daily basis. A recent study at the Tulane University School of Public Health demonstrated that the average blood level of lead found among Americans is high enough to increase the likelihood of heart attack and stroke. In other words, lead toxicity is ubiquitous in America and everyone’s health is compromised to some extent as a result. Chelation therapy—which employs the weak acid EDTA—has the potential to enhance virtually everyone’s health and performance because it removes lead and other toxic heavy metals from our bodies. Although many alternative physicians use EDTA chelation therapy in their practice because of its proven cardiovascular benefits and anti-aging properties, lead removal is the one area where conventional medicine agrees that EDTA chelation therapy should be utilized and we now know that everyone is suffering from enough lead toxicity to—at the very least—increase their risk of cardiovascular disease. But chelation therapy actually does much more than lower your risk of cardiovascular disease and remove lead and other toxic heavy metals from the body. An abundance of compelling scientific evidence suggests that EDTA chelation therapy can dramatically enhance many people’s health and performance. It has been shown to help prevent arteriosclerosis, improve blood circulation, and reduce harmful clotting mechanisms. Some of the other reported benefits from EDTA chelation therapy include better skin texture and skin tone, improvements with arthritis, and better vision and hearing. It has also been shown to reduce blood pressure and cholesterol levels.
Glutathione (GSH) is an important compound naturally present in the body from the time of birth and required until death. It plays a number of roles in the body. As an antioxidant, it neutralizes free radicals and helps maintain Vitamins C and E in reduced (active) state. It also plays a role in detoxification of harmful substances in the body. For instance, a large amount of glutathione will be found in liver helping to neutralize toxins which are then discarded via bile. It also helps in repairing damage to the liver cells caused due to prolonged alcohol abuse or intake of fatty foods. Glutathione has been used to treat diseases including: Alzheimer's, cancer, cystic fibrosis, Parkinson's disease, multiple sclerosis, Huntington's disease and Lyme disease. It has been found that free radicals cause damage to the brain cells due to oxidation; glutathione is effectively used to treat such malaise. At the cost of repetition, it must be mentioned that there are so many positive results with the use of Glutathione IV for treating Parkinson's Disease that it has given new hope to thousands of people suffering from this disease. Glutathione IV in combination with Vitamin C is a popular and effective treatment for getting fairer skin. It reduces the level and distribution of melanin pigment in the skin which results in lessening of the darker tone of the skin. s we grow old, the level of glutathione in the body depletes at the rate of about 10% every ten years. The deficiency leads to health related problems. It has been found that this deficiency can be made up by giving glutathione IV.
IV alpha lipoic acid (ALA) is used to treat cancer (especially pancreatic cancer with metastasis), neuropathy and chronic liver disease. It is a powerful antioxidant, like vitamin C and E, and helps to protect cells from oxidative damage.
IV Phosphatidylcholine therapy involves, administering essential phospholipids in the form of Phosphatidylcholine parenterally (by intravenous infusion) to a patient to reverse age related changes in the lipid composition of organs and tissues, such as heart muscle cells, red blood cells and arteries by lipid exchange. Since the aging process in heart muscle is characterized by a decrease in phosphatidylcholine, and a concomitant increase in sphingomyelin and cholesterol. The treatment is designed to promote exchange of PC to heart cell membrane and exchanges of SM from the heart muscle. The Phosphatidylcholine treatment program is also designed to promote cholesterol exchange from the organs and tissues, such as heart muscle cells, red blood cells and arteries. The most important effect of Phosphatidylcholine is its remarkable ability to reduce plaque depositions in the arterial walls. It also lowers cholesterol and homocysteine levels. Studies in lab animals have shown that it increase their life span by up to 36%. An important therapeutic application of the Phosphatidylcholine treatment program is increasing and individual's ability to withstand cardiac stress. This application is valuable for the individuals who have suffered cardiac trauma, such as myocardial infarction or who are at high risk of heart trauma.
Specific nutrients will be mixed in an IV bag, the IV line will be drawn up and a small butterfly needle will be administered into the appropriate site (usually the forearm). Some discomfort may be be felt during the initial needle insertion, however our staff is trained to provide maximum comfort and the procedure is generally painless. Sessions typically last an hour or a little longer, where you may take a nap, or watch your favorite TV shows if you have a portable DVD player or a tablet device. For questions regarding IV Therapy or to schedule an appointment with the center, please call (310)-326-8625.